Insider Transactions in Q3 2016 at Medtronic PLC (MDT)
Insider Transaction List (Q3 2016)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
17,141
-13.8%
|
$1,474,126
$86.7 P/Share
|
|
Sep 26
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
25,199
-16.86%
|
$2,167,114
$86.67 P/Share
|
|
Sep 26
2016
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
30,624
+17.01%
|
$1,071,840
$35.92 P/Share
|
|
Sep 15
2016
|
Omar Ishrak Executive Chairman |
SELL
Open market or private sale
|
Direct |
61,925
-9.86%
|
$5,201,700
$84.93 P/Share
|
|
Sep 15
2016
|
Kendall J Powell Director |
SELL
Open market or private sale
|
Direct |
7,907
-23.06%
|
$672,095
$85.44 P/Share
|
|
Sep 15
2016
|
Kendall J Powell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,061
+6.2%
|
$452,745
$45.78 P/Share
|
|
Aug 29
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
15,000
-8.92%
|
$1,305,000
$87.0 P/Share
|
|
Aug 29
2016
|
Bryan C Hanson EVP, President, MITG |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.19%
|
$435,000
$29.52 P/Share
|
|
Aug 16
2016
|
Denise M Oleary Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,493
+2.77%
|
$68,678
$46.91 P/Share
|
|
Aug 01
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
BUY
Grant, award, or other acquisition
|
Direct |
16,561
+8.01%
|
-
|
|
Aug 01
2016
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
20,063
+18.16%
|
-
|
|
Aug 01
2016
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
20,441
+16.26%
|
-
|
|
Aug 01
2016
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,328
+10.85%
|
-
|
|
Aug 01
2016
|
Bryan C Hanson EVP, President, MITG |
BUY
Grant, award, or other acquisition
|
Direct |
59,241
+17.12%
|
-
|
|
Aug 01
2016
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,356
+15.11%
|
-
|
|
Aug 01
2016
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
51,102
+7.53%
|
-
|
|
Aug 01
2016
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,063
+20.51%
|
-
|
|
Aug 01
2016
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct |
60,944
+18.61%
|
-
|
|
Aug 01
2016
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
11,356
+17.9%
|
-
|
|
Aug 01
2016
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
9,842
+7.65%
|
-
|
|
Jul 29
2016
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
5,410
-6.02%
|
$470,670
$87.63 P/Share
|
|
Jul 29
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
SELL
Payment of exercise price or tax liability
|
Direct |
7,686
-4.24%
|
$668,682
$87.63 P/Share
|
|
Jul 29
2016
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
28,294
-4.68%
|
$2,461,578
$87.63 P/Share
|
|
Jul 29
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,918
-4.32%
|
$427,866
$87.63 P/Share
|
|
Jul 29
2016
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,821
-6.9%
|
$158,427
$87.63 P/Share
|
|
Jul 29
2016
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
245
-0.79%
|
$21,315
$87.63 P/Share
|
|
Jul 28
2016
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
7,636
-15.79%
|
$664,332
$87.42 P/Share
|
|
Jul 26
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
15,000
-13.8%
|
$1,305,000
$87.0 P/Share
|
|
Jul 26
2016
|
Bryan C Hanson EVP, President, MITG |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+12.12%
|
$435,000
$29.52 P/Share
|
|
Jul 15
2016
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
3,766
-12.54%
|
$331,408
$88.26 P/Share
|
|
Jul 13
2016
|
Shirley A Jackson Director |
SELL
Open market or private sale
|
Direct |
2,104
-5.83%
|
$185,152
$88.64 P/Share
|
|
Jul 13
2016
|
Shirley A Jackson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+3.53%
|
$132,600
$51.59 P/Share
|
|
Jul 13
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
SELL
Open market or private sale
|
Direct |
35,495
-16.4%
|
$3,123,560
$88.64 P/Share
|
|
Jul 13
2016
|
Gary Lee Ellis EVP & Global Ops and IT |
BUY
Exercise of conversion of derivative security
|
Direct |
41,068
+15.95%
|
$1,971,264
$48.7 P/Share
|
|
Jul 06
2016
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
9,787
-14.07%
|
$851,469
$87.08 P/Share
|
|
Jul 05
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
15,272
-14.01%
|
$1,328,664
$87.11 P/Share
|
|
Jul 05
2016
|
Bryan C Hanson EVP, President, MITG |
BUY
Exercise of conversion of derivative security
|
Direct |
15,272
+12.29%
|
$412,344
$27.29 P/Share
|